Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Zi Wang1,2, Bianyin Ma1, Hui Li1

  • 1The State Key Laboratory of Medical Genetics and School of Life Sciences, Central South University, Changsha, China.

Oncotarget
|November 18, 2015
PubMed

Insights

Protein 4.1N acts as a tumor suppressor in non-small cell lung cancer (NSCLC). Its reduced expression promotes tumor growth and metastasis by activating the JNK-c-Jun pathway via PP1, highlighting 4.1N as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein 4.1N is a known tumor suppressor in solid tumors.
  • Its specific role and mechanisms in non-small cell lung cancer (NSCLC) require further investigation.

Purpose of the Study:

  • To investigate the function and underlying mechanisms of Protein 4.1N in NSCLC.
  • To determine the correlation between 4.1N expression and NSCLC progression.
  • To identify molecular interactions and signaling pathways regulated by 4.1N.

Main Methods:

  • Correlation analysis of 4.1N expression with NSCLC cell line metastatic properties and clinical tissue grades.
  • In vitro studies involving knockdown of 4.1N to assess effects on cell proliferation, migration, and adhesion.
  • In vivo studies using mouse xenograft models to evaluate tumor growth and metastasis.
  • Identification of 4.1N-interacting molecules using biochemical assays.
  • Analysis of signaling pathways, including JNK-c-Jun, and their downstream targets.

Main Results:

  • 4.1N expression inversely correlates with NSCLC metastatic potential and tumor grade.
  • Knockdown of 4.1N enhances NSCLC cell proliferation, migration, adhesion, tumor growth, and metastasis.
  • Protein phosphatase 1 (PP1) identified as a novel interacting molecule, with the FERM domain of 4.1N mediating this interaction.
  • Ectopic expression of 4.1N inactivates the JNK-c-Jun pathway by enhancing PP1 activity and its interaction with p-JNK.
  • 4.1N regulates downstream targets of the JNK-c-Jun pathway, including ezrin, MMP9, p53, p21, and p19.

Conclusions:

  • Down-regulation of 4.1N is a critical factor in NSCLC development.
  • 4.1N exerts anti-tumor effects by repressing the JNK-c-Jun signaling pathway through PP1.
  • Targeting 4.1N or its associated pathway presents a potential therapeutic strategy for NSCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K